Publications by authors named "Rogerio Parra"

Claim this Profile
C
Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational study.
Sandro da Costa Ferreira, Rogério Serafim Parra, Ligia Yukie Sassaki, José Miguel Luz Parente, Munique Kurtz de Mello

Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Retrospective Cohort Study.
Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior, Bianca Loyo Pona Schiavetti, Francisco Guilherme Cancela E Penna, Rogério Serafim Parra

J Clin Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positioning and sequencing of advanced therapies in inflammatory bowel disease: A guide for clinical practice.
Marcello Imbrizi, Matheus F C Azevedo, Julio P Baima, Natália S F Queiroz, Rogério S Parra

World J Gastroenterol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.
Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior, Bianca Loyo Pona Schiavetti, Francisco Guilherme Cancela E Penna, Rogério Serafim Parra

Curr Med Res Opin· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of upadacitinib in the management of atopic dermatitis, Crohn's disease, and hidradenitis suppurativa: one treatment, multiple indications.
Roberto Bueno-Filho, Daniel Lorenzini, Rogério Serafim Parra

An Bras Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.
Rogério Serafim Parra, Renata de Sá Brito Fróes, Daniela Oliveira Magro, Sandro da Costa Ferreira, Munique Kurtz de Mello

BMC Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRANSLATION, CROSS-CULTURAL ADAPTATION, AND VALIDATION OF THE IBD DISK FOR USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN THE BRAZILIAN POPULATION.
Cintia Maura Caseiro Nigro, Sandro da Costa Ferreira, Vanessa Foresto Machado, Marley Ribeiro Feitosa, José Joaquim Ribeiro da Rocha, Rogério Serafim Parra

Arq Gastroenterol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn's Disease.
Subrata Ghosh, Brian G Feagan, Rogério Serafim Parra, Susana Lopes, Adam Steinlauf

J Crohns Colitis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperbaric oxygen therapy increases the effect of 5-fluorouracil chemotherapy on experimental colorectal cancer in mice.
Vanessa Foresto Machado, José Joaquim Ribeiro da Rocha, Rogério Serafim Parra, Marley Ribeiro Feitosa, Caio Abner Leite

Med Gas Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.
Jean-Frédéric Colombel, Tadakazu Hisamatsu, Raja Atreya, Francesca Bresso, Lena Thin, Rogério Serafim Parra

Clin Gastroenterol Hepatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukocyte dysfunction and reduced CTLA-4 expression are associated with perianal Crohn's disease.
Murillo Duarte-Silva, Rogério Serafim Parra, Marley Ribeiro Feitosa, Viviani Nardini, Sandra Regina Maruyama

Clin Exp Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with surgical resection in patients with Crohn's disease: long-term evaluation.
Sandro da Costa Ferreira, Lílian Rose Otoboni Aprile, Rogério Serafim Parra, Marley Ribeiro Feitosa, Patrícia Picardi Morais de Castro

Acta Cir Bras· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.
Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo, Liliana Andrade Chebli, Gilmara Pandolfo Zabot

Crohns Colitis 360· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB.
Renata de Sá Brito Fróes, Adriana Ribas Andrade, Mikaell Alexandre Gouvea Faria, Heitor Siffert Pereira de Souza, Rogério Serafim Parra

Sci Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men.
Murillo Duarte-Silva, Camilla N S Oliveira, Carlos Fuzo, Pedro V Silva-Neto, Diana M Toro, Rogerio S Parra

Brain Behav Immun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.
Adriana Zanoni Dotti, Daniela Oliveira Magro, Eduardo Garcia Vilela, Julio Maria Fonseca Chebli, Liliana Andrade Chebli, Rogério Serafim Parra

Crohns Colitis 360· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19.
Diana Mota Toro, Pedro V da Silva-Neto, Jonatan C S de Carvalho, Carlos A Fuzo, Malena M Pérez, Rogerio S Parra

Cells· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective Trial.
Karoline Soares Garcia, Matheus Freitas Cardoso de Azevedo, Alexandre de Sousa Carlos, Luísa Leite Barros, Jane Oba, Rogério Serafim Parra

Biomedicines· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of surgical and oncological results of laparoscopic surgeries performed by residents of coloproctology.
Bárbara Bianca Linhares Mota, Tarcísio Junior Bittencourt Macedo, Rogério Serafim Parra, José Joaquim Ribeiro DA Rocha, Omar Feres

Rev Col Bras Cir· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SURGICAL MANAGEMENT OF ADULT CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN'S DISEASE AND COLITIS (GEDIIB).
Gilmara Pandolfo Zabot, Ornella Sari Cassol, Abel Botelho Quaresma, Francisco de Assis Gonçalves Filho, Júlio Pinheiro Baima, Rogerio Serafim Parra

Arq Gastroenterol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Marcello Imbrizi, Júlio Pinheiro Baima, Matheus Freitas Cardoso de Azevedo, Adriana Ribas Andrade, Natália Souza Freitas Queiroz, Rogerio Serafim Parra

Arq Gastroenterol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Júlio Pinheiro Baima, Marcello Imbrizi, Adriana Ribas Andrade, Liliane Andrade Chebli, Marjorie Costa Argollo, Rogerio Serafim Parra

Arq Gastroenterol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases.
Rogerio Serafim Parra, Sandro da Costa Ferreira, Vanessa Foresto Machado, Cintia Maura Caseiro Nigro, José Joaquim Ribeiro da Rocha

J Clin Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukocytoclastic Vasculitis Secondary to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Diseases: A Multicenter Retrospective Cohort Study.
Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Liliana Andrade Chebli, Sérgio Figueiredo de Lima Junior, Manoel Alvaro Lins Neto

J Clin Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Interplay among Glucocorticoid Therapy, Platelet-Activating Factor and Endocannabinoid Release Influences the Inflammatory Response to COVID-19.
Jonatan C S de Carvalho, Pedro V da Silva-Neto, Diana M Toro, Carlos A Fuzo, Viviani Nardini, Rogerio S Parra

Viruses· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis